← Leaderboards
James D Crapo
University Of Colorado Denver
$109,862,307
Attributed
$109,862,307
Total exposure
18
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.1M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$117,552,834 · 19
By mechanism
U01$59,443,512 · 2
R01$31,121,866 · 1
N01$10,040,949 · 1
P01$8,699,382 · 5
R44$6,001,627 · 1
K30$1,900,000 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Katherina Kechris-Mays$8,836,893
- Farnoush Banaei-Kashani$1,646,406
- Stanley J Szefler$16,550,328
- Daniel L Gustafson$3,654,915
- Lawrence S. Zisman$5,312,556
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseInsightPulmonary EmphysemaX-Ray Computed TomographySyndromeCause Of DeathSmokerGeneticDisorder SubtypeDisease ProgressionGenetic DeterminismCohortOxidative StressChronic Obstructive Airway DiseaseGenome Wide Association StudyGenetic EpidemiologyPredispositionLeadDiagnosticPhenotypeAfrican AmericanClassificationAffectNot Hispanic Or Latino
Grant awards (60)
COPD(GENE): TASK B: "STEWARDSHIP OF BIOSPECIMEN AND DATA REPOSITORIES"$922,055
N01 · FY2024 · HL · contact PI
GENETIC EPIDEMIOLOGY OF COPD (COPD GENE) TASK A: STUDY VISIT 4, COLLECTION OF COPDGENE STUDY DATA ANDBIOSPECIMENS AND OVERSIGHT OF THE COPDGENE STUDY$8,193,539
N01 · FY2023 · HL · contact PI
COPD(GENE): TASK B: "STEWARDSHIP OF BIOSPECIMEN AND DATA REPOSITORIES"$925,355
N01 · FY2023 · HL · contact PI
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas$1,625
R44 · FY2022 · CA · contact PI
(1 of 2) Genetic Epidemiology of COPD$6,661,979
U01 · FY2021 · HL · contact PI
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas$2,000,000
R44 · FY2021 · CA · contact PI
(1 of 2) Genetic Epidemiology of COPD$6,674,407
U01 · FY2020 · HL · contact PI
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas$2,000,000
R44 · FY2020 · CA · contact PI
(1 of 2) Genetic Epidemiology of COPD$6,687,344
U01 · FY2019 · HL · contact PI
(1 of 2) Genetic Epidemiology of COPD$6,699,819
U01 · FY2018 · HL · contact PI
(1 of 2) Genetic Epidemiology of COPD$3,198,864
U01 · FY2017 · HL · contact PI
(1 of 2) Genetic Epidemiology of COPD$3,440,222
R01 · FY2016 · HL · contact PI
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas$1,023,555
R44 · FY2016 · CA · contact PI
(1 of 2) Genetic Epidemiology of COPD$7,477,114
R01 · FY2015 · HL · contact PI
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas$976,447
R44 · FY2015 · CA · contact PI
(1 of 2) Genetic Epidemiology of COPD$7,411,479
R01 · FY2014 · HL · contact PI
Metabolomic signatures of empysema and COPD progression in the COPDGene cohort$170,664
R01 · FY2014 · HL · contact PI
(1 of 2) Genetic Epidemiology of COPD$20,605
R01 · FY2014 · HL · contact PI
(1 of 2) Genetic Epidemiology of COPD$7,200,635
R01 · FY2013 · HL · contact PI
(1 of 2) Genetic Epidemiology of COPD$5,401,147
R01 · FY2012 · HL · contact PI
Genetic Epidemiology of COPD$1,858,987
U01 · FY2011 · HL · contact PI
Genetic Epidemiology of COPD$5,663,290
U01 · FY2010 · HL · contact PI
Building Consensus on Qualitative Chest CT-based Subphenotypes for COPD$25,000
R13 · FY2010 · HL · contact PI
Genetic Epidemiology of COPD$6,586,795
U01 · FY2009 · HL · contact PI
Genetic Epidemiology of COPD$7,227,714
U01 · FY2008 · HL · contact PI
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$22,649
P51 · FY2008 · RR · contact PI
Genetic Epidemiology of COPD$5,604,771
U01 · FY2007 · HL · contact PI
Advanced Training for Clinical Investigators$300,000
K30 · FY2007 · RR · contact PI
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$60,028
P51 · FY2007 · RR · contact PI
Treatment of BPD Using Mimetics of Superoxide Dismutase$398,161
U01 · FY2006 · HL · contact PI
Advanced Training for Clinical Investigators$300,000
K30 · FY2006 · RR · contact PI
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$43,789
P51 · FY2006 · RR · contact PI
Treatment of BPD Using Mimetics of Superoxide Dismutase$397,683
U01 · FY2005 · HL
Advanced Training for Clinical Investigators$300,000
K30 · FY2005 · RR
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$35,323
P51 · FY2005 · RR
ACUTE LUNG INJURY-MECHANISMS AND THERAPY$1,622,450
P01 · FY2004 · HL
Treatment of BPD Using Mimetics of Superoxide Dismutase$386,575
U01 · FY2004 · HL
REGULATION AND FUNCTION OF EXTRACELLULAR SOD$376,406
P01 · FY2004 · HL
ADVANCED TRAINING FOR CLINICAL INVESTIGATORS$200,000
K30 · FY2004 · HL
CORE A-- Administrative Core$152,547
P01 · FY2004 · HL
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$5,516
P51 · FY2004 · RR
ACUTE LUNG INJURY-MECHANISMS AND THERAPY$1,577,182
P01 · FY2003 · HL
Treatment of BPD Using Mimetics of Superoxide Dismutase$384,641
U01 · FY2003 · HL
ADVANCED TRAINING FOR CLINICAL INVESTIGATORS$200,000
K30 · FY2003 · HL
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$3,193
P51 · FY2003 · RR
ACUTE LUNG INJURY-MECHANISMS AND THERAPY$1,533,236
P01 · FY2002 · HL
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$346,148
U01 · FY2002 · HL
ADVANCED TRAINING FOR CLINICAL INVESTIGATORS$200,000
K30 · FY2002 · HL
Data Safety Monitoring and Improved IRB Efficiency$150,000
S07 · FY2002 · RR
REGULATION AND FUNCTION OF EXTRACELLULAR SOD$0
P01 · FY2002 · HL
ACUTE LUNG INJURY-MECHANISMS AND THERAPY$1,490,566
P01 · FY2001 · HL
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$337,410
U01 · FY2001 · HL
ADVANCED TRAINING FOR CLINICAL INVESTIGATORS$200,000
K30 · FY2001 · HL
REGULATION AND FUNCTION OF EXTRACELLULAR SOD$0
P01 · FY2001 · HL
ACUTE LUNG INJURY-MECHANISMS AND THERAPY$1,467,093
P01 · FY2000 · HL
TREATMENT OF BPD USING MIMETICS OF SUPEROXIDE DISMUTASE$328,924
U01 · FY2000 · HL
CORE--PATHOLOGY$239,951
P01 · FY2000 · HL
EXTRACELLULAR SUPEROXIDE DISMUTASE IN AIRWAY AND PULMONARY VASCULAR BIOLOGY$239,951
P01 · FY2000 · HL
ADVANCED TRAINING FOR CLINICAL INVESTIGATORS$200,000
K30 · FY2000 · HL
REGULATION AND FUNCTION OF EXTRACELLULAR SOD$0
P01 · FY2000 · HL